December 19, 2024
When clinical research professionals think about clinical trials, two types often come to mind: those for critically ill patients, where experimental treatments offer a final chance at survival, and those involving healthy volunteers who participate out of altruism, curiosity, or financial incentives. However, a significant and equally important segment of clinical trials lies in the middle: studies targeting individuals managing chronic conditions or living with the risk of future disease.... Read More
October 28, 2024
BRCA1 mutations dramatically increase the lifetime risk of breast, ovarian, pancreatic, and other cancers, yet most BRCA1-positive patients are not identified until after they have been diagnosed with cancer. At prenatal visits, women often undergo obstetrical prenatal carrier screening that can identify hundreds of genetic mutations which can be passed on to offspring and results in an inherited condition — however, BRCA1 and other autosomal dominant mutations are not included on these... Read More
October 18, 2024
According to the National Cancer Institute, there are many ways to reduce your lifetime cancer risk. You can make mindful food choices, refrain from alcohol, maintain a healthy weight, avoid smoking and stay away from known carcinogens. However, no matter how healthy your lifestyle choices may be, there is no way to change your... Read More
August 30, 2024
Here is a video of Breast Cancer Precision Care: A Family Affair | Weill Cornell Medicine
August 28, 2024
In today’s world, genetic testing has become increasingly accessible for more people, creating an increased opportunity for doctors to improve their patients' health. Dr. Melissa Frey, a gynecologic oncologist at NewYork-Presbyterian and Weill Cornell Medicine, is championing an approach known as “cascade genetic testing” to not only learn more about her patient’s cancer risk but to then be able to alert family members of their risk too. As a part of the Genetics and Personalized Cancer... Read More
